ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.8045
0.06%
Brent Oil
84.045
0.11%
Bitcoin
62,929.45
-0.19%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Diplomat Pharmacy Inc (DPLO)

  7. Diplomat Pharmacy Inc (DPLO) Noticias

DPLO

Diplomat Pharmacy (DPLO)

Diplomat Pharmacy Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:DPLO
FechaHoraFuenteTítuloSímboloCompañía
20/02/202005:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NYSE:DPLODiplomat Pharmacy Inc
14/02/202015:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:DPLODiplomat Pharmacy Inc
10/02/202015:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:DPLODiplomat Pharmacy Inc
10/02/202015:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:DPLODiplomat Pharmacy Inc
10/02/202015:03Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NYSE:DPLODiplomat Pharmacy Inc
10/02/202010:24Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NYSE:DPLODiplomat Pharmacy Inc
10/02/202008:20Edgar (US Regulatory)Current Report Filing (8-k)NYSE:DPLODiplomat Pharmacy Inc
07/02/202016:54PR Newswire (US)Generac Holdings Set to Join S&P MidCap 400; Alexander & Baldwin and America's Car-Mart to Join S&P SmallCap 600NYSE:DPLODiplomat Pharmacy Inc
07/02/202007:17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NYSE:DPLODiplomat Pharmacy Inc
07/02/202007:07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NYSE:DPLODiplomat Pharmacy Inc
09/01/202005:33Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NYSE:DPLODiplomat Pharmacy Inc
09/01/202005:10Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NYSE:DPLODiplomat Pharmacy Inc
31/12/201905:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NYSE:DPLODiplomat Pharmacy Inc
19/12/201915:53Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:DPLODiplomat Pharmacy Inc
12/12/201914:00PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc.NYSE:DPLODiplomat Pharmacy Inc
10/12/201915:02Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NYSE:DPLODiplomat Pharmacy Inc
09/12/201906:33Dow Jones NewsDiplomat Pharmacy Shares Tumble on UnitedHealth TakeunderNYSE:DPLODiplomat Pharmacy Inc
09/12/201905:50Dow Jones NewsUnitedHealth to Buy Diplomat at 31% Discount to Friday's Closing PriceNYSE:DPLODiplomat Pharmacy Inc
21/11/201915:48Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:DPLODiplomat Pharmacy Inc
12/11/201915:09Edgar (US Regulatory)Quarterly Report (10-q)NYSE:DPLODiplomat Pharmacy Inc
12/11/201906:30PR Newswire (US)Diplomat Announces 3rd Quarter Financial Results; Updates 2019 GuidanceNYSE:DPLODiplomat Pharmacy Inc
30/10/201915:30PR Newswire (US)Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12NYSE:DPLODiplomat Pharmacy Inc
16/10/201915:30PR Newswire (US)Diplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLCNYSE:DPLODiplomat Pharmacy Inc
02/10/201915:30PR Newswire (US)Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRxNYSE:DPLODiplomat Pharmacy Inc
09/08/201906:31PR Newswire (US)Diplomat Announces 2nd Quarter Financial Results; Updates 2019 GuidanceNYSE:DPLODiplomat Pharmacy Inc
09/08/201906:30PR Newswire (US)Diplomat Announces Review of Strategic AlternativesNYSE:DPLODiplomat Pharmacy Inc
08/08/201916:30PR Newswire (US)Diplomat signs exclusive practice-based infusion agreement with Allergy PartnersNYSE:DPLODiplomat Pharmacy Inc
18/07/201915:30PR Newswire (US)Diplomat to Release Second-Quarter 2019 Operating Results August 9NYSE:DPLODiplomat Pharmacy Inc
15/07/201910:23PR Newswire (US)(DPLO) Alert: Johnson Fistel, LLP Announces Investigation of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged to Conta...NYSE:DPLODiplomat Pharmacy Inc
09/07/201915:30PR Newswire (US)Diplomat Launches Empower Ecosystem Patient Support Digital LibraryNYSE:DPLODiplomat Pharmacy Inc
 Showing the most relevant articles for your search:NYSE:DPLO

Su Consulta Reciente

NASDAQ
TSLA
Tesla
FX
USDMXN
US Dollar vs MXN
AMEX
SPY
SPDR S&P 500
CCOM
US500
US 500
NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados